Actelion Ltd. -- Extended License Agreement for Zavesca
16 juin 2004 01h23 HE
|
Actelion Ltd.
ALLSCHWIL/BASEL, SWITZERLAND and SLOUGH, U.K., June 16, 2004 (PRIMEZONE) -- Actelion Ltd. (SWX:ATLN):
-- Actelion and Celltech extend Zavesca(r) license agreement
-- Celltech grants...
Actelion Provides Update on its Clinical Programs
07 juin 2004 01h25 HE
|
Actelion Ltd.
ALLSCHWIL/BASEL, Switzerland, June 7, 2004 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN):
-- Pivotal tezosentan (VeletriTM) study in Acute Heart Failure
passes first futility analysis
-- Second...
Actelion: Ordinary General Meeting of the Shareholders in Basel, Switzerland
30 avr. 2004 11h11 HE
|
Actelion Ltd.
ALLSCHWIL/BASEL, Switzerland, April 30, 2004 (PRIMEZONE) -- At today's Annual General Meeting of Actelion Ltd (SWX:ATLN), shareholders approved the following resolutions:
-- Increase of conditional...
Actelion Announces First Quarter Results 2004
27 avr. 2004 01h20 HE
|
Actelion Ltd.
ALLSCHWIL/BASEL, Switzerland, April 27, 2004 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) today announced its financial results for the first quarter of 2004. With net revenues of CHF 101.1 million (Q1...
Actelion -- Invitation to Investor Conference Call / Webcast
23 avr. 2004 02h06 HE
|
Actelion Ltd.
ALLSCHWIL, Switzerland, April 23, 2004 (PRIMEZONE) -- Actelion Ltd. (SWX:ATLN): Dear Friend in the Investment Community:
Actelion Ltd. will announce the results of the first quarter 2004 on...
Actelion announces Full Year 2003 financial results
02 mars 2004 02h00 HE
|
Actelion Ltd.
Net revenue up 132% to CHF 307.5 million - Sales of Tracleer(r) continue
to grow - Controlled increase of operating expenses by 88% to
CHF 309.2 m - One-time impact of CHF 47 million...
Actelion / Merck Renin Alliance Achieves First Milestone
02 mars 2004 02h00 HE
|
Actelion Ltd.
ALLSCHWIL, Switzerland, March 2, 2004 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) announced today that the renin alliance with Merck & Co., Inc., (NYSE:MRK) has achieved its first milestone. Actelion...
Actelion adopts US GAAP accounting standard for its financial reporting
12 févr. 2004 01h00 HE
|
Actelion Ltd.
ALLSCHWIL, Switzerland, Feb. 12, 2004 (PRIMEZONE) -- Actelion Ltd (SWX: ATLN) announced today that the US-GAAP compliant statements for the years 2001, 2002 (including footnotes) and the first 9...
Cerep to Acquire Clinical Development Service Organization Hesperion
15 janv. 2004 01h22 HE
|
Actelion Ltd.
ALLSCHWIL, Switzerland and PARIS, Jan. 15, 2004 - Actelion Ltd. (SWX:ATLN) and Cerep (French Nouveau Marche:Cerep) have announced today that Cerep will acquire the clinical development service...
Zavesca(r) Capsules Available for Prescription in the U.S.
05 janv. 2004 12h00 HE
|
Actelion Ltd.
ALLSCHWIL and BASEL, Switzerland, Jan. 5, 2004 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) today announced the availability of Zavesca(r) (miglustat) capsules in the United States. Zavesca(r) is the first...